196 related articles for article (PubMed ID: 19444623)
21. Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells.
Wilhelm O; Weidle U; Höhl S; Rettenberger P; Schmitt M; Graeff H
FEBS Lett; 1994 Jan; 337(2):131-4. PubMed ID: 8287966
[TBL] [Abstract][Full Text] [Related]
22. Effect of bFGF on invasion of ovarian cancer cells through the regulation of Ets-1 and urokinase-type plasminogen activator.
Li T; Jiang S
Pharm Biol; 2010 Feb; 48(2):161-5. PubMed ID: 20645833
[TBL] [Abstract][Full Text] [Related]
23. Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.
So J; Navari J; Wang FQ; Fishman DA
Gynecol Oncol; 2004 Nov; 95(2):314-22. PubMed ID: 15491751
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells.
Tanaka Y; Kobayashi H; Suzuki M; Kanayama N; Terao T
J Biol Chem; 2004 Mar; 279(10):8567-76. PubMed ID: 14676209
[TBL] [Abstract][Full Text] [Related]
25. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Wang FQ; So J; Reierstad S; Fishman DA
Int J Cancer; 2005 Mar; 114(1):19-31. PubMed ID: 15523695
[TBL] [Abstract][Full Text] [Related]
26. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
27. [Effect of antibacterial peptide hCAP18/LL-37 on ovarian cancer microenvironment and the regulatory mechanism of its expression].
Lu Q; Quan W; Wu J; Zhang X; Ma W; Pang L; Li D
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):725-30. PubMed ID: 26813589
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B.
Kobayashi H; Ohi H; Sugimura M; Shinohara H; Fujii T; Terao T
Cancer Res; 1992 Jul; 52(13):3610-4. PubMed ID: 1617632
[TBL] [Abstract][Full Text] [Related]
29. S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
Devine KM; Smicun Y; Hope JM; Fishman DA
Gynecol Oncol; 2008 Aug; 110(2):237-45. PubMed ID: 18513786
[TBL] [Abstract][Full Text] [Related]
30. Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion.
Cooke NM; Spillane CD; Sheils O; O'Leary J; Kenny D
BMC Cancer; 2015 Sep; 15():627. PubMed ID: 26353776
[TBL] [Abstract][Full Text] [Related]
31. HOTAIR Interacting with MAPK1 Regulates Ovarian Cancer skov3 Cell Proliferation, Migration, and Invasion.
Yiwei T; Hua H; Hui G; Mao M; Xiang L
Med Sci Monit; 2015 Jun; 21():1856-63. PubMed ID: 26117268
[TBL] [Abstract][Full Text] [Related]
32. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.
Kaneko T; Konno H; Baba M; Tanaka T; Nakamura S
Cancer Sci; 2003 Jan; 94(1):43-9. PubMed ID: 12708473
[TBL] [Abstract][Full Text] [Related]
33. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.
Guo Y; Cui W; Pei Y; Xu D
Gynecol Oncol; 2019 Jun; 153(3):639-650. PubMed ID: 30928020
[TBL] [Abstract][Full Text] [Related]
34. A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation.
Kobayashi H; Suzuki M; Kanayama N; Terao T
Clin Exp Metastasis; 2004; 21(2):159-66. PubMed ID: 15168733
[TBL] [Abstract][Full Text] [Related]
35. [Study of growth, invasion and metastasis on ovarian epithelial cancer cell line with CCL18 over-expression by mediated in vitro].
Zhang W; Yang YZ; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):528-31. PubMed ID: 24284226
[TBL] [Abstract][Full Text] [Related]
36. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.
Kaliski A; Maggiorella L; Cengel KA; Mathe D; Rouffiac V; Opolon P; Lassau N; Bourhis J; Deutsch E
Mol Cancer Ther; 2005 Nov; 4(11):1717-28. PubMed ID: 16275993
[TBL] [Abstract][Full Text] [Related]
37. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
38. Genetic down-regulation of phosphoinositide 3-kinase by bikunin correlates with suppression of invasion and metastasis in human ovarian cancer HRA cells.
Kobayashi H; Suzuki M; Kanayama N; Terao T
J Biol Chem; 2004 Feb; 279(8):6371-9. PubMed ID: 14597629
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the tumor-associated urokinase-type plasminogen activation system: effects of high-level synthesis of soluble urokinase receptor in ovarian and breast cancer cells in vitro and in vivo.
Magdolen V; Krüger A; Sato S; Nagel J; Sperl S; Reuning U; Rettenberger P; Magdolen U; Schmitt M
Recent Results Cancer Res; 2003; 162():43-63. PubMed ID: 12790320
[TBL] [Abstract][Full Text] [Related]
40. Role of activated protein C in facilitating basement membrane invasion by tumor cells.
Kobayashi H; Moniwa N; Gotoh J; Sugimura M; Terao T
Cancer Res; 1994 Jan; 54(1):261-7. PubMed ID: 8261450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]